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Background: MicroRNA has become important in a wide range of research interests. Due to the increasing number
of known microRNAs, these molecules are likely to be increasingly seen as a new class of biomarkers. This is driven
by the fact that microRNAs are relatively stable when circulating in the plasma. Despite extensive analysis of
mechanisms involved in microRNA processing, relatively little is known about the in vitro decay of microRNAs under
defined conditions or about the relative stabilities of mRNAs and microRNAs.
Methods: In this in vitro study, equal amounts of total RNA of identical RNA pools were treated with different
ribonucleases under defined conditions. Degradation of total RNA was assessed using microfluidic analysis mainly
based on ribosomal RNA. To evaluate the influence of the specific RNases on the different classes of RNA
(ribosomal RNA, mRNA, miRNA) ribosomal RNA as well as a pattern of specific mRNAs and miRNAs was quantified
using RT-qPCR assays. By comparison to the untreated control sample the ribonuclease-specific degradation grade
depending on the RNA class was determined.
Results: In the present in vitro study we have investigated the stabilities of mRNA and microRNA with respect to
the influence of ribonucleases used in laboratory practice. Total RNA was treated with specific ribonucleases and
the decay of different kinds of RNA was analysed by RT-qPCR and miniaturized gel electrophoresis. In addition, we
have examined whether the integrity observed for ribosomal RNA is applicable to microRNA and mRNA. Depending
on the kind of ribonuclease used, our results demonstrated a higher stability of microRNA relative to mRNA and a
limitation of the relevance of ribosomal RNA integrity to the integrity of other RNA groups.
Conclusion: Our results suggest that the degradation status of ribosomal RNA is not always applicable to mRNA
and microRNA. In fact, the stabilities of these RNA classes to exposure to ribonucleases are independent from each
other, with microRNA being more stable than mRNA. The relative stability of microRNAs supports their potential
and further development as biomarkers in a range of applications.
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MicroRNAs (miRNAs) are small, non-coding RNAs which
are encoded within the genome. The primary transcript,
pri-miRNA, contains one or more hairpin structures and is
cleaved to pre-miRNA [1,2]. Upon export to the cytoplasm,
dicer cleaves the pre-miRNA to mature miRNA, which
usually has a length of about 22 ribonucleotides [1,3,4].
Previous studies have suggested that mRNA stability is
an important control point for gene expression regulation
[5]. The mature miRNA plays a key role in the regulation* Correspondence: bernd.denecke@rwth-aachen.de
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article, unless otherwise stated.of their specific target genes [6]. The regulatory function of
miRNA is differentiated into two distinct mechanisms: the
inhibition of target gene expression (i) by inducing the deg-
radation of the target mRNA [4] and/or (ii) by inhibition
of target gene translation [7]. Partial complementary base
pairing causes translational inhibition whereas perfect base
pairing causes degradation of the complementary target
mRNAs. It has long been assumed that translational inhib-
ition is the dominant mechanism, however, recent studies
have shown that the degradation of target mRNA plays the
major role in the inhibition of protein expression [8].
A widespread interest has developed in small non-coding
RNAs for cancer research and drug development. InCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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genesis and are thus promising candidates as potential
therapeutic targets or as biomarkers [9,10]. Moreover, miR-
NAs are able to regulate the expression of multiple genes
and hence affect disease pathways at multiple points [10].
Therefore, miRNAs are promising tools in diagnostic and
therapeutic applications in a wide range of specializations,
including cancer research [11], cardiovascular disease [12],
organ transplantation [13] and rheumatoid arthritis [14].
Although miRNAs comprise an important class mole-
cules used to uncover regulatory mechanisms in the cell,
nearly nothing is known about their decay in comparison
to mRNA under defined in vitro conditions. For this rea-
son, we decided to enhance general knowledge about the
stability of mRNA and miRNA in response to ribonucle-
ases commonly used in routine laboratory practice. We
were interested in finding out how a hypothetical contam-
ination with ribonuclease might affect mRNA and miRNA
stability. Furthermore, we investigated possible differences
in the stability of different classes of RNA (i.e. miRNA,
mRNA or ribosomal RNA). For this purpose, total RNA
was treated in vitro with a range of ribonucleases under
identical experimental conditions and their effects were
analysed by RT-qPCR.
Results
The integrity of ribosomal RNA is affected by treatment
with specific ribonucleases
In contrast to mRNA, which represents only 0.5 to 3% of
the transcriptome, ribosomal RNA is the most prevalentFigure 1 The Stability of ribosomal RNA is affected in a treatment-dependent m
and RNA after treatment with either Benzonase (dark orange), NaOH (pink), RNa
(dark blue) or Exonuclease T (bright blue). Electropherogram of RNA ladder, use
in green. Arbitrary units for fluorescence are given in the ordinate. The untreate
spiked tRNA at about 80 nt, the 18S and the 28S ribosomal RNA. (B) Detection
RNA after indicated treatments is illustrated for three independent experiments
comparison to the untreated RNA is given in the ordinate. The green dotted line
RNA. Significances were calculated by the two tailed unpaired Student’s t-test: *constituent of total RNA in mammalian cells [15]. For this
reason the quality of mRNA is generally extrapolated on
the basis of the quality of ribosomal RNA, which can be
analysed, for example, with microfluidic analysis (Agilent
2100 Bioanalyzer).
Representative electropherograms of our samples that
were analysed with the RNA6000 Nano labchip are
illustrated in Figure 1A. The electropherogram of the un-
treated sample consists of four peaks: i) the loading
marker at 25 nt, ii) the spiked tRNA at about 80 nt, iii) the
18S ribosomal RNA and, iv) the 28S ribosomal RNA. The
tRNA was added after the treatments in order to facilitate
the precipitation of RNA. It was clear that the 18S and
28S ribosomal RNAs were missing after NaOH treatment.
This was expected because NaOH, at the concentration
used, induces the hydrolysis of RNA in a manner that is
independent of size and sequence. Similar to NaOH,
RNase A-treated samples lacked both 18S and 28S peaks.
This indicated that both NaOH and RNase A treatments
significantly affected ribosomal RNA.
In the case of treatment with benzonase and RNase If,
even though the ribosomal peaks were not detectable by
this method, the measured absorption was above the
base line. This is caused by residues of ribosomal RNA.
No specific changes in comparison to the untreated
sample were observed in the electropherograms of the
samples after treatment with RNase H, Exonuclease T or
Exonuclease T7.
In order to determine the decay of ribosomal RNA
after the treatments with a higher sensitivity, a relativeanner. (A) Representative electropherograms of untreated RNA (black)
se A (red), RNase H (grey), RNase If (bright orange), Exonuclease T7
d for size calculation indicated in the abscissa as kilobases (kb), is illustrated
d control sample represents four peaks: the loading marker at 25 nt, the
of 18S ribosomal RNA using RT-qPCR. Percentage of intact 18S ribosomal
with mean and SD (in red). The relative percentage of intact RNA in
represents the 100% intact 18S ribosomal RNA obtained from the untreated
= p < 0.05; *** = p < 0.001. ExoT7 = Exonuclease T7; ExoT = Exonuclease T.
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qPCR (Figure 1B). The percentage of undigested 18S
ribosomal RNA normalised to the untreated control is
presented in Figure 1B. It was observed that, similar to
the results obtained by electrophoresis after treatment
with RNase A or NaOH, a significant reduction of ribo-
somal RNA was detectable (a reduction of 77% and 66%,
respectively). The observed difference in reduction be-
tween the two methods was probably caused by the
higher sensitivity of the RT-qPCR.
A similar effect could be observed after treatment with
benzonase and RNase If. In contrast to a dramatic re-
duction of ribosomal RNA detected by electrophoresis,
the results obtained by RT-qPCR showed only a moder-
ate reduction. In the case of benzonase, this reduction
was significant (p = 0.027). For treatment with RNase If,
a statistically non-significant trend of reduction was
observed.
The treatments with RNase H, Exonucleases T and Exo-
nucleases T7 showed no significant changes compared to
the untreated sample. This confirmed the result obtained
by microfluidic analysis in a quantitative manner.
In the case of RNase If treatment, comparison of sam-
ple electropherograms, which represented the 18S and
28S ribosomal RNAs (Figure 1A), with the results ob-
tained by 18S RT-qPCR (Figure 1B), revealed a discrep-
ancy between these two sets of results. The microfluidic
analysis revealed a partial degradation of 18S and 28S
following treatment with RNase If , while the RT-qPCR
demonstrated only a partial, non-significant digestion of
the 18S ribosomal RNA.
Taken together, these results indicate that, under ex-
perimental conditions, RNase A, benzonase, NaOH and
RNase If treatments cause a total or partial decay of
ribosomal RNA.
Detection of mRNA and miRNA are represented by
targets with different frequencies
Next we asked if the stability of ribosomal RNA to the
various treatments was representative of the stabilities of
mRNA and/or miRNA to the same treatments. This
knowledge is necessary to assess the relative influence of
various treatments on different classes of RNA. For this
reason we performed RT-qPCR for different mRNA and
miRNA targets in the same samples as used for the riboso-
mal RNA analyses.
The mRNA stability was investigated by RT-qPCR for
expression of Hprt (normally used as a reference gene)
[16], Polr2a (normally used as a reference gene) [17],
Nppa (gene expressed in heart muscles) and Nppb (gene
also expressed in heart muscles) [18]. First, we compared
the frequency of the targets analysed in the untreated
samples. As illustrated in Figure 2A, Nppa was most
highly expressed (Cq = 17.9 ± 0.4 cycles), followed byNppb (Cq = 19.8 ± 0.8 cycles), Hprt (Cq = 24.7 ± 0.4 cy-
cles) and Polr2a (Cq = 26.9 ± 0.5 cycles).
On the basis of our previous quantitative studies [19],
miR-1 and miR-208 (cardiac-specific expressed miRNAs)
[20], sno202 (small nuclear RNA 202, often used as a
normalization control) [21], and miR-501 [22] were in-
vestigated as indicators of miRNA stability. Figure 2B il-
lustrates the Cq values of the miRNA targets in the
untreated controls. Sno202 was more highly expressed
in heart tissue than the other miRNAs (Cq = 22.9 ±
0.5 cycles), followed by miR-1 (Cq = 23.3 ± 0.3 cycles)
and miR-208 (Cq = 25.8 ± 0.2 cycles). For miR-501, the
lowest expression was detected (Cq =33.0 ± 0.3 cycles).
To determine whether normalization to a reference gene
influenced the results, we normalized the mRNA values
using Polr2, and the miRNA values using sno202. As il-
lustrated in Figure 2C and D, the distribution of the
delta Cq values looked similar to the Cq values without
normalization. The relatively high standard deviation for
mRNA seems to be caused by the different expression
levels between male and females. Such a gender distinc-
tion was not visible for the analyzed miRNAs.
For both mRNA and miRNA, the selected targets
cover a broad range of expression frequency (Cq 17.9 -
26.9 and Cq 22.9 - 33.0, respectively). This would ensure
the uncovering of potential treatment effects depending
on the frequency of a specific target RNA. However, a
target RNA-dependent frequency was not observed.
Consequently, in order to compensate for the different
target frequencies (i.e to have the result independent
from the original Cq value of each target), we normal-
ized the results to the Cq value of the corresponding un-
treated sample in our further analyses.
Ribonucleases do not have the same effect on different
classes of RNA
Next we considered whether the stability of mRNA and
miRNA was the same after the different treatments. We
measured the relative amount of intact mRNA/miRNA
depending on the different treatments for the selected
targets. In Figure 3, the relative amount of the normal-
ised intact targets is shown as a percentage of untreated
control. For every treatment, the percentages of intact
targets for three independent experiments are repre-
sented for mRNA and miRNA. In addition, the sample
mean and standard deviation are shown. The results
could be divided into five categories.
i) The first category represented the significant decay
of mRNA and miRNA, including treatments with
NaOH and RNase A. The RT-qPCR results for the
mRNA targets suggested the total decay of mRNAs
after the treatment with NaOH or RNase A. Similarly,
after the NaOH treatment, the average of undigested
Figure 2 Analysed targets represent a wide range of quantities. The quantification cycle (Cq), which is inversely proportional to the amount of
target nucleic acid in the sample, was used to calculate the approximate amount of the targets. RT-qPCR analysis was performed with the
untreated RNA isolated from three independent mice hearts (one male - grey, and two female - black). (A) Data-points and the mean of the
Cq values of Nppa (cross), Nppb (downward-pointing triangle), Hprt (open circle) and Polr2a (hexagon) with the SD of three independent experiments
are illustrated. (B) Data-points and the mean of the Cq values of Sno202 (closed circle), miR-1 (asterisk), miR-208 (rhombus) and miR-501 (upwards-
pointing triangle) with the SD of three independent experiments are illustrated. (C) Data-points and the mean of the ΔCq values of Nppa (cross), Nppb
(downward-pointing triangle), Hprt (open circle) and Polr2a (hexagon) with the SD of three independent experiments after normalization with the
reference mRNA Polr2. (D) Data-points and the mean of the ΔCq values of Sno202 (upwards-pointing triangle), miR-1 (closed circle), miR-208 (asterisk)
and miR-501 (rhombus) with the SD of three independent experiments after normalization with the reference small RNA sno202.
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for RNase A-treated samples was more prominent
(i.e. 87.9%). Therefore, these treatments resultedin a severe decay of miRNAs. These results
are consistent with those obtained by
microfluidic analysis and by RT-qPCR for the
Figure 3 mRNA and miRNA stabilities measured by RT-qPCR are
differently influenced depending on the treatment. Percentage of
intact mRNA (blue) and miRNA (black) after indicated treatments are
illustrated for three independent experiments. Nppa, Nppb, Hprt,
and Polr2a were each analysed as targets representative for mRNA
and sno202, miR1, miR208, and miR501 each as targets for miRNA.
The mean with the SD for all analysed targets of each RNA class is
given in violet for mRNA and in red for miRNA. The green dotted
line represents the 100% intact RNA obtained from the untreated
RNA. The ordinate indicates the relative percentage of intact RNA
in comparison to the untreated RNA. Significances were tested by
the two tailed unpaired Student’s t-test: * = p < 0.05; ** = p < 0.01;
*** = p < 0.001. ExoT7 = Exonuclease T7; ExoT = Exonuclease T.
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amount of decay.
ii) The second category consisted of Exonuclease T and
Exonuclease T7 treatments which resulted in the
digestion of mRNAs but not of miRNAs. Although
the reduction of undigested mRNA was only by
about 2% in both cases, it was found to be
significant. As in the case of miRNA, ribosomal
RNA did not show any changes in RNA integrity or
in 18S levels by RT-qPCR (Figure 1).
iii)The third category was represented only by RNase
If. The amounts of intact mRNA and miRNA were
both moderately, but significantly reduced (11.9%
for mRNA and 6.6% for miRNA). This indicated
that RNase If digested miRNA as well as mRNA, but
in a moderate manner. Digestion of ribosomal RNAcould also be observed in the electropherogram of
the microfluidic analysis. However, the partial
digestion of 18S RNA represented by RT-qPCR was
not significant (Figure 1B).
iv) RNase H represented the fourth category, which
caused no effect on mRNA or miRNA or ribosomal
RNA.
v) Benzonase represented the last category. After
treatment with benzonase, a significant reduction of
intact mRNAs was observed (20.4%). Contrary to
this result, no reduction was seen for miRNA. The
partial digestion of ribosomal RNA by benzonase as
analysed by microfluidic analysis and 18S RT-qPCR
was in line with the results of those for mRNA.
Thus, benzonase precisely affected ribosomal RNA
and mRNA, but had no effect on miRNA.
The results of our study indicate that, depending on
the kind of treatment (i.e. ribonucleases), mRNA and
miRNA demonstrate different stabilities. Notably, in com-
parison to mRNA, miRNA frequently presented a higher
level of stability. Taken together, our results indicate that
NaOH and all analysed ribonucleases (except RNase H)
affected mRNA and resulted in the decay of mRNA. On
the one hand, benzonase, Exonuclease T7 and Exonuclease
T significantly affected mRNA but had no significant effect
on decay of miRNA. On the other hand, treatments with
NaOH, RNase A and RNase If also affected miRNA. In
addition, after specific treatments of total RNA, microflui-
dic analyses revealed that ribosomal RNA was degraded
whereas miRNA, as assessed by RT-qPCR, exhibited no
degradation relative to the untreated sample. Hence, we
conclude that there is not always a direct correlation be-
tween the integrity of ribosomal RNA and that of mRNA
or of miRNA.
Discussion
Significant amounts of miRNAs, which are remarkably
stable, can be detected in all biological fluids. This has
favoured the use of miRNAs as a new class of bio-
markers. It is assumed that the high stability of miRNAs
in biological fluids is based on the fact that they are pro-
tected from endogenous RNase activity by being packed
inside exosomes or that they are protected via associ-
ation with an AGO protein complex [23,24]. The pur-
pose of the present study was to investigate the stability
of different classes of RNA (miRNA, mRNA, and rRNA)
against common sources of contamination in a molecu-
lar biology laboratory.
In eukaryotes, the most common method used to as-
sess the integrity of RNA is the measurement of the 28S
to 18S ribosomal RNA where the ratio for intact RNA is
2:1. Previously, this assessment was done by running an
RNA aliquot on a denaturing agarose gel stained with
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SYBR Gold increase the sensitivity, also enabling the de-
tection of lower amounts loaded on the gel. In the
meantime, RNA integrity is assessed using microfluidic
analysis (e.g. Agilent 2100 Bioanalyzer, AdvanceCE™ Nu-
cleic Acids Analyzer, or BioRad Experion). By contrast,
absorbance or fluorescent dye-based procedures are use-
ful for the quantification of RNA and, if necessary, for
the purity. These techniques are, however, unsuitable for
the determination of RNA integrity. The assessment of
mRNA or miRNA integrity in total RNA, independent
of ribosomal RNA, is proving extremely difficult and
mostly includes RT-qPCR. Although there are also
microfluidic analysis assays for small RNAs (e.g. Agilent
small RNA assay) these assays are influenced by total
RNA integrity [25]. For these reasons, microfluidic ana-
lysis of total RNA is widely used for the assessment of
total RNA integrity. The integrity of mRNA and miRNA
is normally extrapolated from the measured ribosomal
integrity.
Our results show that the degradation status of ribo-
somal RNA is not, in all cases, applicable for the deg-
radation status of mRNA and miRNA. In addition, a
class-dependent stability for mRNA, miRNA and ribo-
somal RNA was detected in presence of specific ribo-
nucleases. The class-dependent stability was supported
by the observation that the analysed - RNA class-
specific - targets showed, more or less, the same stabil-
ity. In general, miRNAs revealed more stability than
mRNAs to exposure to ribonucleases and NaOH. This
indicates miRNAs to be good, candidate biomarkers.
Apart from the important regulatory effect of miRNA
on mRNA stability and/or translation [8], the dysregula-
tion of miRNAs can function as a biomarker for use in
cancer diagnosis and for many other diseases [10-14]. In
this context it is important to know if the observed dys-
regulation is due to the regulation process or due to the
differential stabilities of mRNA and miRNA.
Differential stabilities may have extensive consequences
for analysis of the observed data. For instance, in the case
of detection of increased levels of miRNA and a decreased
level of the corresponding target(s) mRNA, the conclusion
would be that the putative down-regulation of mRNA is
due to the regulatory effect of miRNA. However, the lower
stability of mRNA would not have been considered. Nor-
malization to endogenous reference genes is a useful
procedure to correct for sample-to-sample variations in
RT-qPCR efficiency and errors in sample quantification.
The expression is estimated relative to the levels of the
(invariant!) endogenous references [26]. However, this correct-
ive action does not take effect between mRNA and miRNA,
especially if these are degraded with different efficiencies.
Furthermore, we have performed the experiments with
ribonuclesases that are commonly used in a molecularbiology laboratory. These ribonucleases are frequently
connected with a high possibility of reaction contamin-
ation. To our knowledge, up to the time of this study,
there is no information available regarding the in vitro
effect of the analysed ribonucleases on classes of RNA.
In a previous study it was shown that, even in pre-
sumed heat-degraded total RNA, the robust stability of
miRNA enabled its quantification. In contrast, the meas-
urement was no longer possible for mRNA [27]. This
study has also shown that the measured RNA integrity
does not adversely affect the accuracy of RT-qPCR mea-
surements of miRNA, although it significantly affects
the measurement of mRNA [27]. Thus, degradation by
heat results in major effects on mRNA in comparison to
miRNA, and miRNA represents a relatively stable form.
Another study also indicated that miRNA possess dis-
tinct stability. This stability depends on factors such as 7
nucleotides on 3′ terminal or the specific sequences
within a miRNA that make the miRNA a target for ribo-
nucleases. Also, some miRNAs are associated with com-
ponents of RISC such as Ago 2, which also influence the
miRNA stability [28]. However, in this study we were
more interested in comparing the stability of mRNA and
miRNA after treatment with commonly used ribonucle-
ases, being the main source of contamination in routine
molecular biology laboratories. This important aspect
may affect the assessment of RNA quality and thus sub-
sequent results of experiments. Precisely, we have shown
that degradation by different ribonucleases is RNA class-
dependent. Our results also confirmed that RNA integ-
rity would not consistently affect the assessment of the
degradation of miRNA.
RNase A is an endoribonuclease that attacks single-
stranded RNA 3′ to pyrimidine residues and cleaves the
phosphate linkage to the adjacent nucleotide [29,30].
This RNase is one of the major contamination sources
in the molecular biology laboratory. NaOH also catalyses
the breaking of the phosphate backbone in RNA. As ex-
pected, both treatments (RNase A and NaOH) signifi-
cantly decayed all three analysed classes of RNA.
Moreover, RNase If is one of the few known ribonucle-
ases which cleaves the phosphodiester bond between any
two nucleotides [31]. It is a single strand specific endori-
bonuclease. It was reported that RNase If favours the
degradation of small RNA oligonucleotides but also de-
grades long RNA polymers very slowly [32]. This earlier
finding would explain why all three examined classes of
RNA decayed, however, the observable decay for riboso-
mal RNA was not found to be significant.
RNase H cleaves RNA via a hydrolytic mechanism in
DNA/RNA duplexes [33]. This was confirmed in our exper-
iments because no decay was observed in any class of RNA.
It was reported that Exonuclease T7 functions similar
to RNase H on double-stranded DNA/RNA hybrids. It
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hybrid polymers from 5′ terminus [34]. On the other
hand, Exonuclease T is a single stranded RNA or DNA
specific nuclease and removes nucleotides in the 3′ to 5′
direction. Exonuclease T also acts on single-stranded
RNA in a sequence-specific manner. Both Exonucleases
do not decay ribosomal RNA and miRNA but they do
decay mRNA. The small but significant decay of mRNA
by Exonuclease T might be due to sequence specificity
of the enzyme, which has to be clarified in future stud-
ies. The small decay obtained for mRNA after treatment
with Exonuclease T7 might have resulted from undefined
cleavage, which is favoured for mRNA.
Benzonase degrades all forms of DNA and RNA and is
almost capable of cleavage at all positions along a nu-
cleic acid chain. However, a sequence dependency was
demonstrated. A favourable digestion of DNA and RNA
in a double-stranded G- and C-rich sequence has been
reported [29,35]. The reason for the observed missing
decay of miRNA could be explained by the small size of
miRNA. Either small size RNAs, in general, do not act
as a target for benzonase or the probability is very low
that the target sequence is represented in the miRNA.
In the present study we have used RNA from male
and female mouse hearts. This is important to show that
results are consistent across both genders. Also we have
generated the results in three independent experiments
to prove the reproducibility of the results and to high-
light the prominent effect of the ribonucleases. However,
this study can be expanded by providing other RNA
samples or using other treatments. Genome-wide ana-
lyses of the treatment-mediated effects on the different
classes of RNA are possible by using microarray technol-
ogy. Using this method all targets would be amenable to
support the observed RNA class-dependent stability and
thus to generalize our findings. One limitation of our
study was to focus solely on heart tissue, although we
have investigated not only heart-specific mRNAs and
miRNAs but also general expressed targets.
Our study has confirmed the robust stability of miRNA
relative to mRNA. The observed stability is dependent on
the kind of treatment and on the kind of RNA (miRNA,Table 1 Ribonucleases/NaOH treatments with the concentrati
Treatment Units used per ml Supplier
RNase A 3.13 Applichem, Darmstadt, Ge
RNase H 12.50 Ambion, Kassel, Germany
Benzonase 8.33 Sigma, Steinheim, German
Exonuclease T 12.50 New England Biolabs, Fra
Exonuclease T7 12.50 New England Biolabs
RNase If 12.50 New England Biolabs
NaOH 100 μmol ApplichemmRNA and ribosomal RNA). Consequently, the applica-
tion of ribosomal RNA integrity as a proper representative
for mRNA and miRNA integrity should be treated with
caution, as it is not applicable in every case.
Conclusions
In many studies, the putative down regulation of mRNA is
considered to be due to regulatory action of miRNAs. The
different stabilities of RNA classes may cause false inter-
pretations of the observed data, especially when conta-
minations with RNases occur during the experiment.
Therefore it is important to consider and determine the
stability of the respective classes of RNA under the condi-
tions of a given experiment. In our study we could demon-
strate that after exposure to various RNases, miRNA is
equally or even more stable than mRNA. This more
robust stability of miRNAs supports their potential and
further development as biomarkers in a wide range of ap-
plications. Due to the non-uniform stabilities of the vari-
ous RNA classes under certain conditions, the application
of ribosomal RNA as a representative measure of mRNA
or miRNA integrity should be reconsidered.
Methods
Heart isolation and RNA extraction
DBA/2 mice (43 days old) from which hearts were obtained
to isolate the RNA were maintained and sacrificed by cer-
vical dislocation according to the German animal welfare
law (TierSchG: § 7a, Absatz 2, Nummer 1 - 11038A4).
Total RNA from the heart was isolated using peqGOLD
RNAPure according to the manufacturer’s instructions
(PEQLAB Biotechnologie, Erlangen, Germany).
RNases treatment assay
Each the equal amount of total RNA from an identical
RNA pool was used for the different treatments (each
2.5 μg). In a volume of 100 μl total RNA treatment was
performed with indicated ribonucleases or NaOH (Table 1)
at 37°C for 3 min in 1 × reaction buffer (1 mM DTT,
2 mM MgCl2, 2 mM CaCl2, 0.9% NaCl, 50 mM Tris,
pH 8.0). The ribonuclease treatment reactions were
stopped by mixing thoroughly after adding one volume ofon used in this study
Enzyme commission number Literature
rmany EC3.1.27.5 [36,37]
EC3.1.26.4 [38]
y EC3.4.23.1 [39]
nkfurt, Germany EC3.1.3.1 [40-42]
EC3.1.11.3 [34]
EC3.1.27.6 [31,32]
Table 2 TaqMan assays used in this study with the
efficiency rate for each detector
Detector Assay number Efficiency%
Hprt Mm01545399_m1 104.7
Nppa Mm01255747-g1 106.4
Nppb Mm00435304-g1 102.8
Polr2a Mm00839493_m1 94.7
miR208 TM 511 89.5
miR1 TM 2222 103.3
sno202 TM 1232 97.9
miR501 TM 1651 91.6
TaqMan® Ribosomal RNA Control
Reagents
4308329
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The NaOH treatment was stopped by adding the same
molarity of acetic acid by vortexing.
To increase the efficiency of precipitation, a mix of 5 μg
transfer RNA (Sigma) and 1.25 μg Glycogen (Carl Roth) in
a volume of 25 μl was added to the reaction suspension
followed by intensively mixing for 15 sec. Then the sus-
pension was transferred to a phase Lock Gel™ light 1.5 ml
tube (Eppendorf, Hamburg, Germany) and centrifuged for
15 min. Next, a volume of 90 μl of the upper phase was
transferred to a new tube containing 9 μl of 3 M sodium
acetate pH 4.8, mixed and incubated overnight at -20°C
after adding 270 μl of 100% ethanol. The precipitate was
centrifuged for 120 min, washed once with 100 μl of 70%
ethanol, and resuspended in 15 μl of ribonuclease-free
water. All centrifugations were performed at 44,000 × g
and 4°C.
RNA quantification was determined by optical density
(Nanodrop ND-1000, PEQLAB Biotechnologie). For all
analysed RNAs the observed ratio 260/280 was between
1.8 and 2.0. RNA quality (integrity) was assessed using
microfluidic analysis (RNA 6000 Nano kit - Agilent 2100
Bioanalyzer, both Agilent).
Reverse Transcription quantitative Polymerase Chain
Reaction (RT-qPCR)
For mRNA analysis, cDNA was reverse transcribed from
6 μl (40%) of resuspended RNA precipitate (see above)
using Superscript™ II reverse transcriptase, Oligo(dT) 12-
18 and random hexamer primers (all from Applied Biosys-
tem), dNTP mix (Thermo scientific, Bonn, Germany) and
DTT (Invitrogen) according to manufacturer’s instruc-
tions. To quantify the expression of hypoxanthine guanine
phosphoribosyl transferase (Hprt), natriuretic peptide type
A (Nppa), natriuretic peptide type B (Nppb) and DNA-
directed RNA polymerase II polypeptide A (Polr2A) real-
time PCRs using individual TaqMan® Gene Expression
Assays (Applied Biosystems) were performed in triplicates
on an ABI 7300 Real-Time PCR System at 95°C for
10 min, followed by 40 cycles of 95°C for 15 sec and
60°C for 1 min. Subsequently, cDNA was mixed with
TaqMan® Gene Expression Master Mix (Applied Biosys-
tems) and the appropriate TaqMan® Gene Expression As-
says (Applied Biosystems) for the gene of interest (Table 2).
Quantification of selected miRNAs was performed using
individual TaqMan® MicroRNA Assays according to the
manufacturer’s instructions (Applied Biosystems). Shortly,
6 μl (40%) of resuspended RNA precipitate (see above)
were reverse transcribed using the TaqMan® MicroRNA
Reverse Transcription Kit (Applied Biosystems). miR-1,
miR-208, miR-501 and snoRNA202 (Table 2) were quanti-
fied in triplicates on the ABI 7300 Real-Time PCR System
at 95°C for 10 min, followed by 40 cyles of 95°C for 15 sec
and 60°C for 1 min.Quantification of 18S ribosomal RNA was performed in
triplicates with the TaqMan® Ribosomal RNA control re-
agents (Applied Biosystems) in accordance with the manu-
facturer’s instructions on the ABI 7300 Real-Time PCR
System at 50°C for 2 min, 95°C for 10 min, followed by
40 cycles of 95°C for 15 sec and 60°C for 1 min. Assay effi-
ciencies of detectors were determined by serial dilutions
within a 4-log range of the heart total RNA and calculated
with the formula 10-1/slope-1 (Slope =ΔCq/Δlog dilution)
[21] (Table 2).
Since reference genes are also influenced by the
treatments, relative quantification was performed by
normalization to the untreated control. For this purpose,
the Cq value of 40 cycles was assumed to represent the
total digestion of RNA (0% of RNA undigested) and the
Cq value of the untreated control was assigned as not
digested (100% of RNA undigested). The undigested part
after treatment was calculated using the following for-
mula: x = 100 * (40 - Cqtreat)/(40 - Cqunt); [x = percentage
of undigested after treatment, Cqtreat = Cq value of treated
sample, Cqunt = Cq value of untreated sample].Statistical analyses
The data were analysed with the Prism 5.0 software
(©Graphpad Software Inc., USA). The significance was
calculated by the two-tailed unpaired Student’s t-test: *:
p < 0.05; **: p < 0.01; ***: p < 0.001. SD = standard
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